無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の主要国のアレルギー性結膜炎市場:SAC・PAC・VKC・AKC・GPC

Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type(SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, etc) Companies, Growth Drivers & Challenges

発行 Renub Research 商品コード 781815
出版日 ページ情報 英文 127 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.75円で換算しております。
Back to Top
世界の主要国のアレルギー性結膜炎市場:SAC・PAC・VKC・AKC・GPC Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type(SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, etc) Companies, Growth Drivers & Challenges
出版日: 2019年02月01日 ページ情報: 英文 127 Pages
概要

世界のアレルギー性結膜炎の市場は2025年には20億米ドルを超える規模に成長すると予測されています。

当レポートでは、世界のアレルギー性結膜炎の市場を調査し、疾患の概要、市場規模および患者数・治療中の患者数の推移と予測、疾患区分別の市場シェア、主要国別の詳細分析、上市済み薬・パイプライン薬のプロファイル、市場成長への各種影響因子の分析、主要企業のプロファイル・取り組みなどをまとめています。

第1章 エグゼクティブサマリー

第2章 アレルギー性結膜炎:世界の市場規模・患者数

  • アレルギー性結膜炎市場
  • 患者数
  • 治療中の患者数

第3章 アレルギー性結膜炎市場:市場シェアの推移・予測

  • 国別シェア
  • 患者人口のシェア
  • 治療中の患者数のシェア
  • 疾患タイプ別シェア

第4章 インド

  • 患者数
  • 治療中の患者数
  • アレルギー性結膜炎市場

第5章 中国

  • 患者数
  • 治療中の患者数
  • アレルギー性結膜炎市場

第6章 日本

  • 患者数
  • 治療中の患者数
  • アレルギー性結膜炎市場

第7章 米国

  • 患者数
  • 治療中の患者数
  • アレルギー性結膜炎市場

第8章 英国

  • 患者数
  • 治療中の患者数
  • アレルギー性結膜炎市場

第9章 フランス

  • 患者数
  • 治療中の患者数
  • アレルギー性結膜炎市場

第10章 ドイツ

  • 患者数
  • 治療中の患者数
  • アレルギー性結膜炎市場

第11章 イタリア

  • 患者数
  • 治療中の患者数
  • アレルギー性結膜炎市場

第12章 スぺイン

  • 患者数
  • 治療中の患者数
  • アレルギー性結膜炎市場

第13章 世界のアレルギー性結膜炎市場:疾患タイプ別

  • 季節性アレルギー性結膜炎 (SAC)・通年性アレルギー性結膜炎 (PAC)
  • 春季カタル (VKC)
  • アトピー性角結膜炎 (AKC)
  • 巨大乳頭結膜炎 (GPC)

第14章 上市済み薬・パイプライン薬のプロファイル

  • Zerviate
  • OTX-DP (デキサメタゾンインサート)
  • ADX-102
  • PRT2761
  • CVXL-0074
  • AK-002
  • ベルチリムマブ
  • Reproxalap
  • ST-266
  • SYL-116011

第15章 成長推進因子

第16章 課題

第17章 Santen Pharmaceutical

  • 企業概要
  • イニチアチブ・取り組み
  • 財務分析

第18章 Alcon Inc. (Novartis)

  • 企業概要
  • イニチアチブ・取り組み
  • 財務分析

第19章 Portola Pharmaceuticals Inc.

  • 企業概要
  • イニチアチブ・取り組み
  • 財務分析

第20章 Ocular Therapeutix Inc.

  • 企業概要
  • イニチアチブ・取り組み
  • 財務分析
図表

List of Figures:

Figure 2 1: Global - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 2 2: Global - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 2 3: Global - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 2 4: Global - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 2 5: Global - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 2 6: Global - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 3 1: Global - Allergic Conjunctivitis Market Country Share (Percent), 2013 - 2018

Figure 3 2: Global - Forecast for Allergic Conjunctivitis Market Country Share (Percent), 2019 - 2025

Figure 3 3: Global - Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2013 - 2018

Figure 3 4: Global - Forecast for Allergic Conjunctivitis Treated Patients Population Country Share (Percent), 2019 - 2025

Figure 3 5: Global - Allergic Conjunctivitis Disease Type Market Share (Percent), 2013 - 2018

Figure 3 6: Global - Forecast for Allergic Conjunctivitis Disease Type Market Share (Percent), 2019 - 2025

Figure 4 1: India - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 4 2: India - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 4 3: India - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 4 4: India - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 4 5: India - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 4 6: India - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 5 1: China - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 5 2: China - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 5 3: China - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 5 4: China - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 5 5: China - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 5 6: China - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 6 1: Japan - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 6 2: Japan - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 6 3: Japan - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 6 4: Japan - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 6 5: Japan - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 6 6: Japan - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 7 1: United States - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 7 2: United States - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 7 3: United States - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 7 4: United States - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 7 5: United States - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 7 6: United States - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 8 1: United Kingdom - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 8 2: United Kingdom - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 8 3: United Kingdom - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 8 4: United Kingdom - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 8 5: United Kingdom - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 8 6: United Kingdom - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 9 1: France - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 9 2: France - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 9 3: France - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 9 4: France - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 9 5: France - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 9 6: France - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 10 1: Germany - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 10 2: Germany - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 10 3: Germany - Allergic Conjunctivitis Patient Treated Numbers (Million), 2013 - 2018

Figure 10 4: Germany - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 10 5: Germany - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 10 6: Germany - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 11 1: Italy - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 11 2: Italy - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 11 3: Italy - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 11 4: Italy - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 11 5: Italy - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 11 6: Italy - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 12 1: Spain - Allergic Conjunctivitis Patient Numbers (Million), 2013 - 2018

Figure 12 2: Spain - Forecast for Allergic Conjunctivitis Patient Numbers (Million), 2019 - 2025

Figure 12 3: Spain - Allergic Conjunctivitis Treated Patient Numbers (Million), 2013 - 2018

Figure 12 4: Spain - Forecast for Allergic Conjunctivitis Treated Patient Numbers (Million), 2019 - 2025

Figure 12 5: Spain - Allergic Conjunctivitis Market (Million US$), 2013 - 2018

Figure 12 6: Spain - Forecast for Allergic Conjunctivitis Market (Million US$), 2019 - 2025

Figure 13 1: Global - Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2013 - 2018

Figure 13 2: Global - Forecast for Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Market (Million US$), 2019 - 2025

Figure 13 3: Global - Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2013 - 2018

Figure 13 4: Global - Forecast for Vernal Keratoconjunctivitis (VKC) Market (Million US$), 2019 - 2025

Figure 13 5: Global - Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2013 - 2018

Figure 13 6: Global - Forecast for Atopic Keratoconjunctivitis (AKC) Market (Million US$), 2019 - 2025

Figure 13 7: Global - Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2013 - 2018

Figure 13 8: Global - Forecast for Giant Papillary Conjunctivitis (GPC) Market (Million US$), 2019 - 2025

Figure 14 1: Allergic Conjunctivitis Pipe Line Drug - Zerviate Status (2018)

Figure 14 2: Allergic Conjunctivitis Pipe Line Drug - OTX-DP (Dexamethasone Insert) Status (2018)

Figure 14 3: Allergic Conjunctivitis Pipe Line Drug - ADX-102 Status (2018)

Figure 14 4: Allergic Conjunctivitis Pipe Line Drug - PRT-2761Status (2018)

Figure 14 5: Allergic Conjunctivitis Pipe Line Drug - CVXL-0074 Status (2018)

Figure 14 6: Allergic Conjunctivitis Pipe Line Drug - AK-002 Status (2018)

Figure 14 7: Allergic Conjunctivitis Pipe Line Drug - Bertilimumab Status (2018)

Figure 14 8: Allergic Conjunctivitis Pipe Line Drug - Reproxalap Status (2018)

Figure 14 9: Allergic Conjunctivitis Pipe Line Drug - ST-266 Status (2018)

Figure 14 10: Allergic Conjunctivitis Pipe Line Drug - SYL-116011 Status (2018)

Figure 17 1: Santen Pharmaceutical - Global Revenue (Million US$), 2014 - 2018

Figure 17 2: Santen Pharmaceutical - Forecast for Global Revenue (Million US$), 2019 - 2025

Figure 18 1: Alcon (Novartis) - Global Revenue (Million US$), 2014 - 2018

Figure 18 2: Alcon (Novartis) - Forecast for Global Revenue (Million US$), 2019 - 2025

Figure 19 1: Portola Pharmaceuticals - Global Revenue (Thousand US$), 2014 - 2018

Figure 19 2: Portola Pharmaceuticals - Forecast for Global Revenue (Thousand US$), 2019 - 2025

Figure 20 1: Ocular Therapeutix - Global Revenue (Thousand US$), 2014 - 2018

Figure 20 2: Ocular Therapeutix - Forecast for Global Revenue (Thousand US$), 2019 - 2025

List of Tables:

Table 3 1: Global - Allergic Conjunctivitis Patients Population Country Share (Percent), 2013 - 2018

Table 3 2: Global - Forecast for Allergic Conjunctivitis Patients Population Country Share (Percent), 2019 - 2025

目次

Allergic conjunctivitis is a kind of eye disease in which it affect the eye surfaces and are commonly associated to immune-mediated inflammatory reactions of these structures. The prevalence of the allergic conjunctivitis is found more in summer and spring across the various regions. Pollen, dust, irritants such as cigarette smoke, perfumes etc. are some of the substance that triggers the conjunctivitis. Itching is the most typical sign of allergic conjunctivitis, and more than 75 percent of patients report this symptom when seeking treatment. According to Renub Research Allergic Conjunctivitis Market is expected to be more than USD 2 Billion market by 2025.

Global allergic conjunctivitis market will grow due to increasing prevalence of various allergic conjunctivitis, development in medical infrastructure in the developing countries, growing awareness about allergic conjunctivitis among people, increasing ageing population and upcoming therapies such as Zerviate, ADX-102, PRT-2761, OTX-DP etc. Allergic conjunctivitis are classified mainly in five types: Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) and Giant Papillary Conjunctivitis (GPC).

Renub Research report titled "Global Allergic Conjunctivitis Market, Patients, Treated Patients By Countries (India, China, Japan, United States, United Kingdom, France, Germany, Italy, Spain), Disease Type (Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC), Vernal Keratoconjunctivitis (VKC), Atopic Keratoconjunctivitis (AKC) And Giant Papillary Conjunctivitis (GPC)), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) Companies (Santen Pharmaceutical, Alcon (Novartis), Portola Pharmaceuticals, Ocular Therapeutix), Growth Drivers, Challenges" provides a complete analysis of global allergic conjunctivitis market.

China Dominates the Global Allergic Conjunctivitis Patient Population

In this report, we have shown complete insight of country analysis of allergic conjunctivitis patient population. The covered countries are; India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. China dominates the global allergic conjunctivitis patient population numbers.

United States is the leading Country in the Global Allergic Conjunctivitis Market

Allergic conjunctivitis market is growing across all parts of the world. Market growth rates varies in the countries covered in the report India, China, Japan, United States, United Kingdom, France, Germany, Italy and Spain. United States is leading country in the global allergic conjunctivitis market due to growing awareness, strong healthcare support system and large patient population.

Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC) Hold Majority of Market in the Global Allergic Conjunctivitis Market

On the basis of disease type, global Allergic conjunctivitis market is further segmented into seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) market, vernal keratoconjunctivitis (VKC) market, atopic keratoconjunctivitis (AKC) market and giant papillary conjunctivitis (GPC) market, globally. Seasonal allergic conjunctivitis (SAC) & perennial allergic conjunctivitis (PAC) hold majority of market share in the global allergic conjunctivitis market.

Allergic Conjunctivitis Pipe Line Drugs are Key Strength for this Market Place

In the global allergic conjunctivitis market, allergic conjunctivitis pipe line drugs will play the major role for the growth of this market. At present several drugs such as Zerviate, OTX-DP, ADX-102, PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011 etc. are in preclinical, IND, Phase I, Phase II and Phase III stage.

Report has been analyzed from 9 Major Viewpoints:

  • 1. Global Allergic Conjunctivitis Market
  • 2. Global Allergic Conjunctivitis Market Share, Disease Type Market Share, Patients Share, Treated Patients Share
  • 3. Country Allergic Conjunctivitis Market
  • 4. Country Allergic Conjunctivitis Patients Population
  • 5. Country Allergic Conjunctivitis Treated Patients Population
  • 6. Disease Type Allergic Conjunctivitis Market
  • 7. Allergic Conjunctivitis Drugs Pipeline
  • 8. Growth Drivers and Challenges
  • 9. Key Allergic Conjunctivitis Companies Initiatives and Financial Insight

Country Covered - Global Allergic Conjunctivitis Market

  • India
  • China
  • Japan
  • United States
  • United Kingdom
  • France
  • Germany
  • Italy
  • Spain

Disease Type Covered - Global Allergic Conjunctivitis Market

  • Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
  • Vernal Keratoconjunctivitis (VKC)
  • Atopic Keratoconjunctivitis (AKC)
  • Giant Papillary Conjunctivitis (GPC)

Drugs Profile Covered - Global Allergic Conjunctivitis Market

  • Zerviate
  • OTX-DP
  • ADX-102
  • PRT-2761
  • CVXL-0074
  • AK-002
  • Bertilimumab
  • Reproxalap
  • ST-266
  • SYL-116011

Company Covered

  • Santen Pharmaceutical
  • Alcon (Novartis)
  • Portola Pharmaceuticals
  • Ocular Therapeutix

Table of Contents

1. Executive Summary

2. Global Allergic Conjunctivitis Market and Patients Analysis

  • 2.1 Allergic Conjunctivitis Market
  • 2.2 Allergic Conjunctivitis Patient Numbers
  • 2.3 Allergic Conjunctivitis Treated Patient Numbers

3. Share Analysis - Global Allergic Conjunctivitis

  • 3.1 Country Market Share
  • 3.2 Patients Population Share
  • 3.3 Treated Patients Population Share
  • 3.4 By Disease Type Share

4. India

  • 4.1 Allergic Conjunctivitis Patient Numbers
  • 4.2 Allergic Conjunctivitis Treated Patient Numbers
  • 4.3 Allergic Conjunctivitis Market

5. China

  • 5.1 Allergic Conjunctivitis Patient Numbers
  • 5.2 Allergic Conjunctivitis Treated Patient Numbers
  • 5.3 Allergic Conjunctivitis Market

6. Japan

  • 6.1 Allergic Conjunctivitis Patient Numbers
  • 6.2 Allergic Conjunctivitis Treated Patient Numbers
  • 6.3 Allergic Conjunctivitis Market

7. United States

  • 7.1 Allergic Conjunctivitis Patient Numbers
  • 7.2 Allergic Conjunctivitis Treated Patient Numbers
  • 7.3 Allergic Conjunctivitis Market

8. United Kingdom

  • 8.1 Allergic Conjunctivitis Patient Numbers
  • 8.2 Allergic Conjunctivitis Treated Patient Numbers
  • 8.3 Allergic Conjunctivitis Market

9. France

  • 9.1 Allergic Conjunctivitis Patient Numbers
  • 9.2 Allergic Conjunctivitis Treated Patient Numbers
  • 9.3 Allergic Conjunctivitis Market

10. Germany

  • 10.1 Allergic Conjunctivitis Patient Numbers
  • 10.2 Allergic Conjunctivitis Treated Patient Numbers
  • 10.3 Allergic Conjunctivitis Market

11. Italy

  • 11.1 Allergic Conjunctivitis Patient Numbers
  • 11.2 Allergic Conjunctivitis Treated Patient Numbers
  • 11.3 Allergic Conjunctivitis Market

12. Spain

  • 12.1 Allergic Conjunctivitis Patient Numbers
  • 12.2 Allergic Conjunctivitis Treated Patient Numbers
  • 12.3 Allergic Conjunctivitis Market

13. Disease Type - Global Allergic Conjunctivitis Market

  • 13.1 Seasonal Allergic Conjunctivitis (SAC) & Perennial Allergic Conjunctivitis (PAC)
  • 13.2 Vernal Keratoconjunctivitis (VKC)
  • 13.3 Atopic Keratoconjunctivitis (AKC)
  • 13.4 Giant Papillary Conjunctivitis (GPC)

14. Global Allergic Conjunctivitis Drugs Profile/Pipe Line Drugs

  • 14.1 Zerviate
  • 14.2 OTX-DP (Dexamethasone Insert)
  • 14.3 ADX-102
  • 14.4 PRT2761
  • 14.5 CVXL-0074
  • 14.6 AK-002
  • 14.7 Bertilimumab
  • 14.8 Reproxalap
  • 14.9 ST-266
  • 14.10 SYL-116011

15. Growth Driver

  • 15.1 Rapid Urbanization and Growth of Particulate Pollution
  • 15.2 Increasing Ageing Population & Widespread Use of Medications for Various Eye Diseases

16. Challenges

  • 16.1 Diagnostic Challenges
  • 16.2 Undertreated by Patients

17. Santen Pharmaceutical

  • 17.1 Company Overview
  • 17.2 Initiatives
    • 17.2.1 Point 1
    • 17.2.2 Point 2
  • 17.3 Financial Insight

18. Alcon Inc. (Novartis)

  • 18.1 Company Overview
  • 18.2 Initiatives
    • 18.2.1 Point 1
    • 18.2.2 Point 2
  • 18.3 Financial Insight

19. Portola Pharmaceuticals Inc.

  • 19.1 Company Overview
  • 19.2 Initiatives
    • 19.2.1 Point 1
    • 19.2.2 Point 2
  • 19.3 Financial Insight

20. Ocular Therapeutix Inc.

  • 20.1 Company Overview
  • 20.2 Initiatives
    • 20.2.1 Point 1
    • 20.2.2 Point 2
  • 20.3 Financial Insight
Back to Top